March 20, 2017
Pharmacosmos has signed up as sponsor at the 9th
European Symposium of Porcine Health Management. in Prague/Czech
Republic - from the 3rd - 5th of May
2017.
We welcome new and existing Uniferon customers to visit our
exhibition where we would be pleased to inform you about Uniferon
and discuss optimized anaemia care.
Visit us at our Exhibition stand S5. Find
the position on the image below.
For additional information about ESPHM 2017, please
visit: www.esphm2017.org
Click to enlarge
About Uniferon
Uniferon is a modern improved iron hydrogenated dextran based on
a natural formula, which is approved for global use:
Uniferon is manufactured without the use of any organic solvents
or cyanide, thus, avoiding trace residues of these impurities.
Pharmacosmos manufactures iron dextran of high quality and unique
purity for customers worldwide. Uniferon is the only injectable
iron brand for piglets approved in the EU, the US and Asia.
About Pharmacosmos
Headquartered in Denmark, Pharmacosmos is a family-owned,
international healthcare company with more than 50 years of
innovation and leadership in iron- and carbohydrate-based
treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses
on improving the lives of patients with iron deficiency with or
without anaemia. More than 1 billion people live with iron
deficiency anaemia and it is the leading cause of death for an
estimated 180,000 people every year. This makes it one of the
largest global health challenges of our time.
Pharmacosmos has subsidiaries in the Nordics, the UK and the US
and its products are marketed in more than 80 countries across the
world. Its manufacturing facilities are approved, among others, by
the Danish Medicines Agency and the US FDA.